Jeffrey B. Mirviss - 16 Feb 2024 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP&Pres, Periph Intervent
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
16 Feb 2024
Net transactions value
-$273,811
Form type
4
Filing time
20 Feb 2024, 21:04:53 UTC
Previous filing
16 Feb 2024
Next filing
22 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +2,970 +4.1% $0.000000 75,574 16 Feb 2024 Direct F1
transaction BSX Common Stock Tax liability $89,186 -1,355 -1.8% $65.82 74,219 16 Feb 2024 Direct
transaction BSX Common Stock Options Exercise $0 +3,333 +4.5% $0.000000 77,552 17 Feb 2024 Direct F1
transaction BSX Common Stock Tax liability $100,046 -1,520 -2% $65.82 76,032 17 Feb 2024 Direct
transaction BSX Common Stock Options Exercise $0 +2,817 +3.7% $0.000000 78,849 18 Feb 2024 Direct F2
transaction BSX Common Stock Tax liability $84,579 -1,285 -1.6% $65.82 77,564 18 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Options Exercise $0 -2,970 -33% $0.000000 5,940 16 Feb 2024 Common Stock 2,970 Direct F1, F3
transaction BSX Restricted Stock Units Options Exercise $0 -3,333 -50% $0.000000 3,334 17 Feb 2024 Common Stock 3,333 Direct F1, F4
transaction BSX Deferred Stock Units Options Exercise $0 -2,817 -100% $0.000000* 0 18 Feb 2024 Common Stock 2,817 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock.
F3 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F4 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
F5 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.